“Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin)” (2023) Eurasian Journal of Research, Development and Innovation, 26, pp. 1–4. Available at: https://geniusjournals.org/index.php/ejrdi/article/view/5178 (Accessed: 30 January 2026).